Blood vessel smooth muscle cell contraction

Blood vessel smooth muscle cell contraction is a key physiological process in which vascular smooth muscle cells (VSMCs), primarily located in the medial layer of blood vessels, contract to regulate blood vessel diameter and blood pressure. This process is mediated by a balance of intracellular calcium signaling, activation of contractile proteins (actin and myosin), and the phosphorylation cycles of myosin light chains. Key molecular mechanisms involve calcium-dependent pathways (mediated by calmodulin and myosin light chain kinase) and calcium-independent pathways (notably the RhoA/Rho-kinase pathway). Activation can occur via multiple stimuli, including mechanical stretch, electrical depolarization, and a range of vasoactive chemicals binding to G protein–coupled receptors (such as adrenergic, angiotensin II, endothelin-1, and vasopressin receptors). Relaxation is mediated via nitric oxide and cGMP, and by dephosphorylation of myosin light chains. This process is fundamental for regulating vascular tone, distributing blood flow, and maintaining hemodynamic stability. Dysregulation contributes to conditions such as hypertension and vascular disease

Other names

Vascular smooth muscle contractionBlood vessel vascular smooth muscle cell contractionVasoconstrictionVascular tone regulation

Inhibition of L-type calcium channels to reduce calcium influx and induce relaxation (calcium channel blockers)\n Activation or inhibition of G protein–coupled receptors (e.g., adrenergic, angiotensin II, endothelin receptors) to modulate contractile signaling\n Modulation of cAMP/cGMP pathways to regulate myosin light chain phosphorylation\n Inhibition of myosin light chain kinase (MLCK) activity or activation of myosin light chain phosphatase (MLCP) to regulate contraction and relaxation